Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 10:32 am Purchase | 13G | Immunovant Inc. IMVT | FMR LLC | 12,537,571 8.565% | 4,661,749 (+59.19%) | View |
| 2024-02-14 08:47 am Sale | 13G | Immunovant Inc. IMVT | Deep Track Capital LP | 1,000,000 0.690% | -8,710,000 (-89.70%) | View |
| 2024-02-09 09:16 am Purchase | 13G | Immunovant Inc. IMVT | FMR LLC | 7,875,822 5.444% | 7,875,822 (New Position) | View |
| 2023-10-04 5:19 pm Purchase | 13D | Immunovant Inc. IMVT | Roivant Sciences Ltd. ROIV | 79,815,331 55.300% | 6,416,667 (+8.74%) | View |
| 2023-02-14 08:37 am Purchase | 13G | Immunovant Inc. IMVT | Deep Track Capital LP | 9,710,000 7.520% | 2,929,173 (+43.20%) | View |
| 2022-12-05 4:09 pm Sale | 13G | Immunovant Inc. IMVT | RTW INVESTMENTS LP | 0 0.000% | -8,459,241 (Position Closed) | View |
| 2022-12-02 4:06 pm Purchase | 13G | Immunovant Inc. IMVT | RTW INVESTMENTS LP | 8,459,241 6.540% | 866,988 (+11.42%) | View |
| 2022-02-11 5:11 pm Purchase | 13G | Immunovant Inc. IMVT | Deep Track Capital LP | 6,780,827 5.830% | 6,780,827 (New Position) | View |
| 2021-08-02 08:23 am Purchase | 13D | Immunovant Inc. IMVT | Roivant Sciences Ltd. ROIV | 73,398,664 63.800% | 17,021,276 (+30.19%) | View |
| 2021-03-08 08:00 am Unchanged | 13D | Immunovant Inc. IMVT | Roivant Sciences Ltd. ROIV | 56,377,388 57.500% | 0 (Unchanged) | View |
| 2021-02-16 10:37 am Purchase | 13G | Immunovant Inc. IMVT | RTW INVESTMENTS LP | 7,592,253 7.750% | 7,592,253 (New Position) | View |
| 2020-09-18 4:32 pm Purchase | 13D | Immunovant Inc. IMVT | Roivant Sciences Ltd. ROIV | 56,377,388 57.600% | 8,773,969 (+18.43%) | View |
| 2020-09-04 5:29 pm Purchase | 13D | Immunovant Inc. IMVT | Roivant Sciences Ltd. ROIV | 47,603,419 54.200% | 380,000 (+0.80%) | View |
| 2020-05-14 7:24 pm Purchase | 13D | Immunovant Inc. IMVT | Roivant Sciences Ltd. ROIV | 47,223,419 62.100% | 8,773,969 (+22.82%) | View |
| 2020-04-17 5:27 pm Purchase | 13D | Immunovant Inc. IMVT | Roivant Sciences Ltd. ROIV | 38,449,450 58.200% | 1,034,483 (+2.76%) | View |
| 2020-04-09 5:13 pm Unchanged | 13G | Immunovant Inc. IMVT | WONG RODERICK | 4,426,106 7.800% | 0 (Unchanged) | View |
| 2020-02-14 4:05 pm Purchase | 13G | Immunovant Inc. IMVT | Cormorant Asset Management LP | 1,080,000 1.910% | 1,080,000 (New Position) | View |
| 2020-02-14 08:23 am Unchanged | 13G | Immunovant Inc. IMVT | Governors Lane LP | 0 0.000% | 0 (Unchanged) | View |
| 2020-02-12 5:02 pm Unchanged | 13G | Immunovant Inc. IMVT | BOOTHBAY FUND MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | View |
| 2020-02-12 4:40 pm Purchase | 13G | Immunovant Inc. IMVT | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,020,000 3.550% | 1,020,000 (New Position) | View |